Besides, circFNDC3B competitively binds to miR-1178-3p, resulting in decreased expression of G3BP2, and then inhibits the downstream SRC/FAK signaling pathway to impair tumor growth and lymphatic metastasis in bladder cancer [15]. The gene discussed is PTK2; the disease is urinary bladder carcinoma.